|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
12 March 2018 |
|
Main ID: |
ChiCTR-INR-17011160 |
|
Date of registration:
|
2017-04-16 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The influence of ultrasound-guided abdominal regional nerve block optimization for postoperative pain and forward prognosis
|
|
Scientific title:
|
The influence of ultrasound-guided abdominal regional nerve block optimization for postoperative pain and forward prognosis |
|
Date of first enrolment:
|
2017-04-17 |
|
Target sample size:
|
control group:25;TAP regular group:25;TAP fentanyl group:25;TAP dex group:25; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=18966 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
New Treatment Measure Clinical Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Chen Qi
|
|
Address:
|
181 Hanyu Road, Shapingba District, Chongqing, China
400030
|
|
Telephone:
|
+86 15123864518 |
|
Email:
|
nicholas0518@foxmail.com |
|
Affiliation:
|
ChongQing Cancer Hospital |
|
|
Name:
|
Yang Bin
|
|
Address:
|
181 Hanyu Road, Shapingba District, Chongqing, China
|
|
Telephone:
|
+86 18581288032 |
|
Email:
|
amyangbin@163.com |
|
Affiliation:
|
ChongQing Cancer Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients aged 18-60 years who underwent open operation of gynecologic malignant tumors were enrolled in an informed consent from at the ASA I-II.
Exclusion criteria: Patient's refusal,coagulopathy,infection at the needle insertion,allergy to local anesthetics.
Age minimum:
18
Age maximum:
60
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Abdominal surgery
|
|
Intervention(s)
|
|
control group:only PCIA for analgesia;TAP regular group:0.375% ropivacaine;TAP fentanyl group:0.375% ropivacaine combined with fentanyl;TAP dex group:0.375% ropivacaine combined with Dexmedetomidine;
|
|
Primary Outcome(s)
|
|
first bolus time of PCA postoperation;QoR-40 questionnaire;
|
|
Secondary Outcome(s)
|
|
score of VAS postoperation;total use of opioids postoperation;
|
|
Source(s) of Monetary Support
|
|
Self-raised
|
|
Ethics review
|
Status: Approved
Approval date: 11/04/2017
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|